Report
Note: Workshop Summaries contain the opinion of the presenters, but do NOT reflect the conclusions of the IOM. Learn more about the differences between Workshop Summaries and Consensus Reports.
Until fairly recently, genetic information was used primarily in the diagnosis of relatively rare genetic diseases, such as cystic fibrosis and Huntington's Disease, but a transformation in the use of genetic and genomic information is underway. While many predictions have been made that genomics will transform medicine, to date few of these promising discoveries have resulted in actual applications in medicine and health.
The Institute of Medicine's Roundtable on Translating Genomic-Based Research for Health, established in 2007, held its first workshop to address the following questions:
- Are there different pathways by which new scientific findings move from the research setting into health care?
- If so, what are the implications of those different pathways for genomics?
- What can we learn from the translation of other new technologies as we seek to understand the translation of genome science into health care?
Information obtained from the workshop was then used to further discussion and exploration of the answers to these questions. The workshop report summarizes speaker presentations and discussions. Any conclusions reported should not be construed as reflecting a group consensus, rather they are the statements and opinions of presenters and participants.
Other Reports by this Activity
Displaying: 3 of 7 Reports
-
Integrating Large-Scale Genomic Information into Clinical Practice - Workshop Summary
As the technology and affordability of genomic sequencing continues to evolve and the clinical applications for genomics-based research increase, it is important to address how genomics data can best be integrated into the clinical setting. On July 19, 2011, the IOM’s Roundtable on Translating Genomic-Based Research for Health hosted a workshop to highlight and identify the challenges and opportunities in integrating large-scale genomic information into clinical practice. Challenges for realizing genomic medicine range from the analysis, interpretation, and delivery of genetic information to associated workforce, ethical, and legal issues.
Released: November 11, 2011
-
Generating Evidence for Genomic Diagnostic Test Development – Workshop Summary
Ten years after the sequencing of the human genome, scientists have developed genetic tests that can predict a person’s response to certain drugs, estimate the risk of developing Alzheimer’s disease, and make other predictions based on known links between genes and diseases. However, genetic tests have yet to become a routine part of medical care, in part because there is not enough evidence to show they help improve patients’ health. The IOM held a workshop to explore how researchers can gather better evidence more efficiently on the clinical utility of genetic tests.
Released: May 6, 2011
-
Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development - Workshop Summary
Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts. The IOM held a workshop on July 22, 2010, to explore these issues and develop solutions.
Released: December 16, 2010
Future Meeting for this Activity
View Agenda
Previous Meeting for this Activity